InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-6.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Singh Shawn, Chairman & CEO. Insider active across 1 company, notably VistaGen Therapeutics, Inc.. In total, 11 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €101k. History available since 30 June 2021. The latest transaction was filed on 28 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
4,854 shares@ US$2.9585.5% of flowCommon StockSEC:0001415889-24-019020:0
167 shares@ US$1.7170.1% of flowCommon StockSEC:0001415889-24-000344:0
167 shares@ US$1.58950.1% of flowCommon StockSEC:0001415889-23-010721:0
5,000 shares@ US$0.08760.2% of flowCommon StockSEC:0001415889-23-000041:0
600,000 shares@ US$0.17241.8% of flowCommon StockSEC:0001415889-22-008814:0
Ideal exit: 14 May 2023 (T+270)
5,000 shares@ US$0.7481.5% of flowCommon StockSEC:0001415889-22-007688:0
100,000 shares@ US$1.000.39% mcap78.1% of flowCommon StockSEC:0001415889-22-004988:0
3,623 shares@ US$1.65752.2% of flowCommon StockSEC:0001415889-22-000034
3,623 shares@ US$1.65750.021% mcap4.3% of flowCommon StockSEC:0001415889-22-000034:0
5,000 shares@ US$1.94653.4% of flowCommon StockSEC:0001415889-21-003387
5,000 shares@ US$1.94650.033% mcap6.7% of flowCommon StockSEC:0001415889-21-003387:0
11 of 11 declarations
About Singh Shawn
Shawn Singh is the Chief Executive Officer of VistaGen Therapeutics, Inc. He is responsible for the strategic and operational leadership of the company. Singh plays a key role in innovation and growth, guiding the organization towards its objectives. His leadership is essential for ensuring the success and sustainability of the company.
